Joannis E. Vamvakopoulos
Rational Drug Design Program
Biomedicum Helsinki
PO Box 63 (Haartmaninkatu 8)
00014 Helsinki
Finland
Name/email consistency: high
- Three's company: regulation of cell fate by statins. Vamvakopoulos, J.E. Curr. Drug. Targets. Cardiovasc. Haematol. Disord (2005)
- HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. Vamvakopoulos, J.E., Green, C. BMC. Cardiovasc. Disord (2003)